Onconetix (ONCO) Competitors $0.06 +0.01 (+9.39%) Closing price 04:00 PM EasternExtended Trading$0.06 +0.00 (+7.58%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ONCO vs. ABVC, NRSN, COCP, PHIO, INAB, CLRB, ME, MBRX, UPXI, and IMNNShould you be buying Onconetix stock or one of its competitors? The main competitors of Onconetix include ABVC BioPharma (ABVC), NeuroSense Therapeutics (NRSN), Cocrystal Pharma (COCP), Phio Pharmaceuticals (PHIO), IN8bio (INAB), Cellectar Biosciences (CLRB), 23andMe (ME), Moleculin Biotech (MBRX), Upexi (UPXI), and Imunon (IMNN). These companies are all part of the "pharmaceutical products" industry. Onconetix vs. ABVC BioPharma NeuroSense Therapeutics Cocrystal Pharma Phio Pharmaceuticals IN8bio Cellectar Biosciences 23andMe Moleculin Biotech Upexi Imunon ABVC BioPharma (NASDAQ:ABVC) and Onconetix (NASDAQ:ONCO) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, dividends, community ranking, earnings, analyst recommendations, profitability, institutional ownership, valuation and risk. Which has stronger valuation & earnings, ABVC or ONCO? ABVC BioPharma has higher earnings, but lower revenue than Onconetix. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioABVC BioPharma$509.79K25.74-$10.52M-$0.47-1.77Onconetix$1.87M2.05-$37.41MN/AN/A Do insiders and institutionals have more ownership in ABVC or ONCO? 11.4% of ABVC BioPharma shares are held by institutional investors. Comparatively, 23.9% of Onconetix shares are held by institutional investors. 11.9% of ABVC BioPharma shares are held by insiders. Comparatively, 11.4% of Onconetix shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Does the MarketBeat Community prefer ABVC or ONCO? ABVC BioPharma and Onconetix both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformABVC BioPharmaN/AN/AOnconetixN/AN/A Is ABVC or ONCO more profitable? ABVC BioPharma has a net margin of -1,619.65% compared to Onconetix's net margin of -2,758.89%. Onconetix's return on equity of 0.00% beat ABVC BioPharma's return on equity.Company Net Margins Return on Equity Return on Assets ABVC BioPharma-1,619.65% -104.94% -56.81% Onconetix -2,758.89%N/A -48.09% Does the media refer more to ABVC or ONCO? In the previous week, ABVC BioPharma and ABVC BioPharma both had 2 articles in the media. Onconetix's average media sentiment score of 0.02 beat ABVC BioPharma's score of -0.04 indicating that Onconetix is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ABVC BioPharma 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Onconetix 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Which has more risk and volatility, ABVC or ONCO? ABVC BioPharma has a beta of 0.33, suggesting that its share price is 67% less volatile than the S&P 500. Comparatively, Onconetix has a beta of 3.51, suggesting that its share price is 251% more volatile than the S&P 500. SummaryOnconetix beats ABVC BioPharma on 6 of the 10 factors compared between the two stocks. Get Onconetix News Delivered to You Automatically Sign up to receive the latest news and ratings for ONCO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ONCO vs. The Competition Export to ExcelMetricOnconetixPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.83M$6.48B$5.30B$7.33BDividend YieldN/A3.21%5.44%4.33%P/E RatioN/A6.9221.8217.82Price / Sales2.05243.09386.15100.16Price / CashN/A65.6738.2034.62Price / Book0.026.136.604.03Net Income-$37.41M$142.00M$3.20B$247.35M7 Day PerformanceN/A6.41%2.97%2.84%1 Month PerformanceN/A-8.58%-7.51%-5.02%1 Year PerformanceN/A-2.79%14.40%1.23% Onconetix Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ONCOOnconetix0.8714 of 5 stars$0.06+9.4%N/A-98.9%$3.83M$1.87M0.0012Short Interest ↓ABVCABVC BioPharma0.8419 of 5 stars$0.87+2.1%N/A-11.8%$13.77M$509,788.00-1.0130Earnings ReportNRSNNeuroSense Therapeutics0.2731 of 5 stars$1.00-3.2%N/A-29.6%$13.67MN/A-1.5610Short Interest ↑COCPCocrystal Pharma1.9424 of 5 stars$1.34+1.9%$7.00+424.2%-12.7%$13.58MN/A-0.7210Gap UpPHIOPhio Pharmaceuticals2.4035 of 5 stars$2.83+3.7%$4.00+41.3%-50.9%$13.52MN/A-0.2610Gap DownINABIN8bio3.5322 of 5 stars$0.17+3.3%$6.00+3,510.1%-83.9%$13.51MN/A-0.2220Positive NewsCLRBCellectar Biosciences2.2443 of 5 stars$0.29-2.9%$12.50+4,207.4%-90.4%$13.37MN/A-0.1710Analyst ForecastShort Interest ↓Gap UpME23andMe0.4215 of 5 stars$0.50-35.3%N/A-94.8%$13.36M$208.78M-0.03770Gap DownHigh Trading VolumeMBRXMoleculin Biotech2.2383 of 5 stars$0.95+8.6%$6.00+531.4%-79.6%$13.30MN/A0.0020Short Interest ↑UPXIUpexi1.1907 of 5 stars$9.89+330.0%N/A+3.6%$13.07M$18.63M0.00130News CoverageGap DownHigh Trading VolumeIMNNImunon2.1091 of 5 stars$0.89-0.2%$21.50+2,319.8%-24.1%$12.99M$500,000.00-0.4730Short Interest ↑News Coverage Related Companies and Tools Related Companies ABVC Alternatives NRSN Alternatives COCP Alternatives PHIO Alternatives INAB Alternatives CLRB Alternatives ME Alternatives MBRX Alternatives UPXI Alternatives IMNN Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ONCO) was last updated on 4/22/2025 by MarketBeat.com Staff From Our PartnersREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredVirtually Limitless Energy?A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discov...Stansberry Research | SponsoredTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Onconetix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Onconetix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ONCO Stock Free ONCO Stock Alerts